Concourse Financial Group Securities, Inc. Global Blood Therapeutics, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$22.3 - $37.39 $3,679 - $6,169	165 Added 62.26%	430 $14,000
Q1 2022 May 09, 2022	SELL	$25.68 - $35.59 $4,494 - $6,228	-175 Reduced 39.77%	265 $9,000
Q4 2021 Feb 07, 2022	SELL	$24.9 - $40.26 $373 - $603	-15 Reduced 3.3%	440 $13,000
Q2 2021 Aug 13, 2021	BUY	$32.46 - $43.42 $5,355 - $7,164	165 Added 56.9%	455 $15,000
Q4 2020 Feb 02, 2021	BUY	$37.65 - $63.77 $564 - $956	15 Added 5.45%	290 $13,000
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $4,570 - $8,186	100 Added 57.14%	275 $22,000
Q2 2019 Aug 13, 2019	BUY	$52.6 - $63.29 $9,205 - $11,075	175 New	175 $9,000
Q1 2019 May 15, 2019	BUY	$39.99 - $53.48 $0 - $0	0 New	0 $0
Q4 2018 Feb 14, 2019	BUY	$31.54 - $46.67 $0 - $0	0 New	0 $0
Q3 2018 Nov 13, 2018	BUY	$38.0 - $51.1 $0 - $0	0 New	0 $0

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account